GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Judkowski, Valeria ^a   Bunying, Alcinette ^a   Ge, Feng ^a   Appel, Jon R ^a   Law, Kingyee ^a   Sharma, Atima ^a   Gabaglia, Claudia ^a   Norori, Patricia ^a   Santos, Radleigh G ^a   Giulianotti, Marc A ^a   Slifka, Mark K ^b   Douek, Daniel C ^c   Graham, Barney S ^c   Pinilla, Clemencia ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SMALLPOX VACCINE; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN; HLA DR ANTIGEN; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IN VITRO STUDY; MOLECULAR LIBRARY; PROTEIN ANALYSIS; VACCINIA; AMINO ACID SEQUENCE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL LINE; IMMUNOLOGY; METABOLISM; SMALLPOX; VACCINATION; VACCINIA VIRUS;

VACCINIA VIRUS; VARIOLA VIRUS;

AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; SMALLPOX; SMALLPOX VACCINE; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINIA; VACCINIA VIRUS;

EID: 80052583882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024091     Document Type: Article

References (62)

1. Rosenthal SR, Merchlinsky M, Kleppinger C, Goldenthal KL, (2001) Developing new smallpox vaccines. Emerg Infect Dis 7: 920-926.
2. Amara RR, Nigam P, Sharma S, Liu J, Bostik V, (2004) Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J Virol 78: 3811-3816.
3. Rock MT, Yoder SM, Wright PF, Talbot TR, Edwards KM, et al. (2005) Differential Regulation of Granzyme and Perforin in Effector and Memory T Cells following Smallpox Immunization. J Immunol 174: 3757-3764.
4. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, et al. (2003) Duration of antiviral immunity after smallpox vaccination. Nat Med 9: 1131-1137.
5. Sivapalasingam S, Kennedy JS, Borkowsky W, Valentine F, Zhan MX, et al. (2007) Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. J Infect Dis 195: 1151-1159.
6. Crotty S, Felgner PL, Davies H, Glidewell J, Villarreal L, et al. (2003) Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171: 4969-4973.
7. Hammarlund E, Lewis MW, Hanifin JM, Mori M, Koudelka CW, et al. (2010) Antiviral immunity following smallpox virus infection: a case-control study. J Virol 84: 12754-12760.
8. Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, et al. (2008) Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28: 847-858.
9. Borras-Cuesta F, Golvano J, Garcia-Granero M, Sarobe P, Riezu-Boj J, et al. (2000) Specific and general HLA-DR binding motifs: comparison of algorithms. Hum Immunol 61: 266-278.
10. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S, (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
11. Tang J, Murtadha M, Schnell M, Eisenlohr LC, Hooper J, et al. (2006) Human T-cell responses to vaccinia virus envelope proteins. J Virol 80: 10010-10020.
12. Kennedy RB, Poland GA, (2010) The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins. Virology 408: 232-240.
13. Jing L, Davies DH, Chong TM, Chun S, McClurkan CL, et al. (2008) An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T cell profiling. J Virol 82: 7120-7134.
14. Jing L, Chong TM, Byrd B, McClurkan CL, Huang J, et al. (2007) Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus. J Immunol 178: 6374-6386.
15. Jing L, McCaughey SM, Davies DH, Chong TM, Felgner PL, et al. (2009) ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J Immunol Methods 347: 36-45.
16. Calvo-Calle JM, Strug I, Nastke MD, Baker SP, Stern LJ, (2007) Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection. PLoS Pathog 3: 1511-1529.
17. Mitra-Kaushik S, Cruz J, Stern LJ, Ennis FA, Terajima M, (2007) Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses. J Immunol 179: 1303-1312.
18. Moise L, McMurry JA, Buus S, Frey S, Martin WD, et al. (2009) In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. Vaccine 27: 6471-6479.
19. Strug I, Calvo-Calle JM, Green KM, Cruz J, Ennis FA, et al. (2008) Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor. J Proteome Res 7: 2703-2711.
20. Zhao Y, Gran B, Pinilla C, Markovic-Plese S, Hemmer B, et al. (2001) Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J Immunol 167: 2130-2141.
21. Zhao Y, Grover L, Simon R, (2001) TEST: A web-based T-cell epitope search tool pp. 493-497.
22. Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, et al. (2007) Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals. Vaccine 25: 1513-1525.
23. Billiau A, Matthys P, (2009) Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 20: 97-113.
24. Seder RA, Darrah PA, Roederer M, (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247-258.
25. Abdalla AO, Kiaii S, Hansson L, Rossmann ED, Jeddi-Tehrani M, et al. (2003) Kinetics of cytokine gene expression in human CD4+ and CD8+ T-lymphocyte subsets using quantitative real-time PCR. Scand J Immunol 58 (6): 601-606.
26. Littaua RA, Takeda A, Cruz J, Ennis FA, (1992) Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. J Virol 66: 2274-2280.
27. Amanna IJ, Slifka MK, (2011) Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411: 206-215.
28. Amanna IJ, Slifka MK, Crotty S, (2006) Immunity and immunological memory following smallpox vaccination. Immunol Rev 211: 320-337.
29. Puissant-Lubrano B, Bossi P, Gay F, Crance JM, Bonduelle O, et al. (2010) Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans. J Clin Invest.
30. McKinney BA, Reif DM, Rock MT, Edwards KM, Kingsmore SF, et al. (2006) Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis 194: 444-453.
31. Reif DM, Motsinger-Reif AA, McKinney BA, Rock MT, Crowe JE, et al. (2009) Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination. Genes Immun 10: 112-119.
32. Topalian SL, Rivoltini L, Mancini M, Markus NR, Robbins PF, et al. (1994) Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci U S A 91: 9461-9465.
33. Shi Y, Liu CH, Roberts AI, Das J, Xu G, et al. (2006) Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res 16: 126-133.
34. Mueller H, Detjen AK, Schuck SD, Gutschmidt A, Wahn U, et al. (2008) Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 43 (2): 143-148.
35. Faist B, Fleischer B, Jacobsen M, (2010) Cytomegalovirus infection- and age-dependent changes in human CD8+ T-cell cytokine expression patterns. Clin Vaccine Immunol 17: 986-992.
36. Scriba TJ, Tameris M, Mansoor N, Smit E, van der ML, et al. (2010) Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol 40: 279-290.
37. Ullenhag GJ, Spendlove I, Watson NF, Indar AA, Dube M, et al. (2006) A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55. Clin Cancer Res 12: 7389-7396.
38. Ryan JE, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, et al. (2009) Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods 341: 97-105.
39. Mangada MM, Rothman AL, (2005) Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175: 2676-2683.
40. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, et al. (2006) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24: 341-348.
41. Liu L, Xu Z, Fuhlbrigge RC, Pena-Cruz V, Lieberman J, et al. (2005) Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J Virol 79: 7363-7370.
42. Huaman MC, Martin LB, Malkin E, Narum DL, Miller LH, et al. (2008) Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteers. J Immunol 180: 1451-1461.
43. Sorkness RL, Gern JE, Grindle KA, Mosser AG, Rosenthal LA, et al. (2002) Persistence of viral RNA in 2 rat strains differing in susceptibility to postbronchiolitis airway dysfunction. J Allergy Clin Immunol 110: 607-609.
44. Nuara AA, Walter LJ, Logsdon NJ, Yoon SI, Jones BC, et al. (2008) Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Proc Natl Acad Sci U S A 105: 1861-1866.
45. Sakala IG, Chaudhri G, Buller RM, Nuara AA, Bai H, et al. (2007) Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. J Virol 81: 3346-3353.
46. Zaunders JJ, Dyer WB, Munier ML, Ip S, Liu J, et al. (2006) CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells. J Virol 80: 10151-10161.
47. Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, et al. (1999) Identification of candidate T cell epitopes and molecular mimics in chronic Lyme Disease. Nature Med 5: 1375-1382.
48. Sospedra M, Zhao Y, zur Hausen H, Muraro PA, Hamashin C, et al. (2005) Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 1: e41.
49. Venturini S, Allicotti G, Zhao Y, Simon R, Burton DR, et al. (2006) Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4(+) T cell clone. Eur J Immunol 36: 27-36.
50. Rubio-Godoy V, Ayyoub M, Dutoit V, Servis C, Schink A, et al. (2002) Combinatorial peptide library based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity. Eur J Immunol 32: 2292-2299.
51. Nino-Vasquez JJ, Allicotti G, Borras E, Wilson DB, Valmori D, et al. (2004) A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol Immunol 40: 1063-1074.
52. Markovic-Plese S, Hemmer B, Zhao Y, Simon R, Pinilla C, et al. (2005) High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis. J Neuroimmunol 169: 31-38.
53. Lewinsohn DA, Winata E, Swarbrick GM, Tanner KE, Cook MS, et al. (2007) Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 3: 1240-1249.
54. Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, et al. (2005) Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 102: 547-552.
55. Davies DH, Molina DM, Wrammert J, Miller J, Hirst S, et al. (2007) Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7: 1678-1686.
56. Davies DH, Wyatt LS, Newman FK, Earl PL, Chun S, et al. (2008) Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol 82: 652-663.
57. Benhnia MR, McCausland MM, Su HP, Singh K, Hoffmann J, et al. (2008) Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J Virol 82: 3751-3768.
58. Assarsson E, Greenbaum JA, Sundstrom M, Schaffer L, Hammond JA, et al. (2008) Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A 105: 2140-2145.
59. Barsov EV, Andersen H, Coalter VJ, Carrington M, Lifson JD, et al. (2005) Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett 105: 26-37.
60. Miller G, Lipman M, (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 70: 190-194.
61. Houghten RA, (1985) General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 82: 5131-5135.
62. Pinilla C, Appel JR, Houghten RA, (1994) Investigation of antigen-antibody interactions using a soluble nonsupport-bound synthetic decapeptide library composed of four trillion sequences. Biochem J 301: 847-853.